SupplierRadar
Sign inStart free

Quinfica Nutramedics Boldo

FDA import alert and refusal historyGuatemala, GuatemalaFEI 3006800203

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Quinfica Nutramedics Boldo.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectQuinfica Nutramedics Bold added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

As of October 26, 2026, Quinfica Nutramedics Boldo is not on any FDA import alert in SupplierRadar's records; FDA refused 7 of its shipment lines between August 22, 2025 and September 26, 2025, most often for unapproved new drug (UNAPPROVED).

Data from FDA public records, last checked . Request a correction

Current status

Import alerts
Not listed
Last import refusal
Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c. · UNAPPROVED
Last warning letter
None found
Last inspection
None on record

Every FDA record for Quinfica Nutramedics Boldo

7 records, newest first. Each line links to the FDA page it came from.

2025

  1. Import refusal
    Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry 799-0936617-3
    Source
  2. Import refusal
    Refused, 2 lines in one entry: Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry 799-1075638-8Show 2 lines
    • Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry 799-1075638-8Source
    • Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry 799-1075638-8Source
    Source
  3. Import refusal
    Refused, 2 lines in one entry: Sodium ascorbate (vitamin); Vitamin b12 (cyanocobalamin)UNAPPROVEDEntry 799-1074891-4Show 2 lines
    Source
  4. Import refusal
    Refused, 2 lines in one entry: Vitamin b12 (cyanocobalamin); Sodium ascorbate (vitamin)UNAPPROVEDEntry 799-0895227-0Show 2 lines
    Source

Refusal charges, in plain English

  • UNAPPROVED7 refused lines

    Unapproved new drug

    The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Quinfica Nutramedics Boldo

Is Quinfica Nutramedics Boldo on an FDA import alert?
No listing for Quinfica Nutramedics Boldo appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Guatemala page.
Has FDA refused shipments from Quinfica Nutramedics Boldo?
Yes. FDA refused 7 shipment lines from Quinfica Nutramedics Boldo between August 22, 2025 and September 26, 2025. The most recent, on September 26, 2025, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as UNAPPROVED (unapproved new drug).
Why did FDA refuse Quinfica Nutramedics Boldo's shipments?
The most frequent charge is UNAPPROVED (unapproved new drug, 7 lines).
What is Quinfica Nutramedics Boldo's FEI number?
Quinfica Nutramedics Boldo's FDA Establishment Identifier (FEI) is 3006800203.

Buying from Quinfica Nutramedics Boldo?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Quinfica Nutramedics Boldo.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectQuinfica Nutramedics Bold added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.